Venous (Vein) Thrombosis Therapeutics Clinical Trials Market Review Report Available at MarketOptimizer.org

Share Article

MarketOptimizer.org adds “Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Venous (Vein) Thrombosis.

Venous (Vein) Thrombosis Therapeutics Market

Venous (Vein) Thrombosis Therapeutics Market

A venous thrombus is a blood clot (thrombus) that forms within a vein. Thrombosis is a term for a blood clot occurring inside a blood vessel. A common type of venous thrombosis is a deep vein thrombosis (DVT), which is a blood clot in the deep veins of the leg. If the thrombus breaks off (embolizes) and flows towards the lungs, it can become a life-threatening pulmonary embolism (PE), a blood clot in the lungs. When a blood clot breaks loose and travels in the blood, this is called a venous thromboembolism (VTE). The abbreviation DVT/PE refers to a VTE where a deep vein thrombosis (DVT) has moved to the lungs (PE or pulmonary embolism). An inflammatory reaction is usually present, mainly in the superficial veins and, for this reason this pathology is called most of the time thrombophlebitis. In fact, the inflammatory reaction and the white blood cells play a role in the resolution of venous clots.

Clinical trial report, “Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014″ provides data on the Venous (Vein) Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous (Vein) Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous (Vein) Thrombosis.

Complete report available @ http://www.marketoptimizer.org/venous-vein-thrombosis-global-clinical-trials-review-h2-2014.html .

Scope

  •     Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  •     Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  •     Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

  •     Understand the dynamics of a particular indication in a condensed manner
  •     Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  •     Obtain discontinued trial listing for trials across the globe
  •     Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=11397 .

Clinical Trial Overview of Top Companies:

  •     Bayer AG
  •     C. H. Boehringer Sohn AG & Co. KG
  •     GlaxoSmithKline plc
  •     Pfizer Inc.
  •     Sanofi
  •     Bristol-Myers Squibb Company
  •     Daiichi Sankyo Company, Limited
  •     The LEO Foundation
  •     AstraZeneca PLC
  •     Astellas Pharma Inc.

Clinical Trial Overview of Top Institutes / Government:

  •     Brigham and Women’s Hospital
  •     Ottawa Hospital Research Institute
  •     Academic Medical Center
  •     Hamilton Health Sciences
  •     McMaster University
  •     University of Vermont
  •     St. Orsola Hospital
  •     Washington University School of Medicine
  •     Centre Hospitalier Universitaire de Saint Etienne
  •     Azienda Ospedaliera Universitaria Policlinico catania

List of Tables
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Venous (Vein) Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Venous (Vein) Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Venous (Vein) Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Venous (Vein) Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Venous (Vein) Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Browse more reports on Pharmaceuticals Market @ http://www.marketoptimizer.org/category/life-sciences/pharmaceuticals .

About Us:
MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@RnRMR
since: 06/2012
Follow >
RnR Market Research
since: 08/2012
Like >
Follow us on
Visit website